{"nct_id":"NCT01609231","title":"A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025)","status":"TERMINATED","status_verified_date":"2020-04","start_date":"2012-07-06","start_date_type":"ACTUAL","primary_completion_date":"2014-12-09","primary_completion_date_type":"ACTUAL","completion_date":"2014-12-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}